QuidelOrtho Manager Says High-Sensitivity Troponin Speeds Heart Attack Diagnosis

Reuters
02/19
QuidelOrtho Manager Says High-Sensitivity Troponin Speeds Heart Attack Diagnosis

QuidelOrtho Corporation released episode 56 of its *Science Bytes* podcast featuring Dr. Lindy Carlstrom, Global Medical Affairs Manager for Acute Care, discussing how high-sensitivity troponin testing can enable earlier detection of cardiac injury, improve reproducibility at low troponin levels, and support faster emergency department rule-out pathways such as 0/1- or 0/2-hour protocols. The conversation also highlighted the role of sex-specific cutoffs in improving diagnostic equity and pointed to emerging research applications including cardio-oncology, perioperative care, and long-term risk prediction. Full episode: https://www.quidelortho.com/global/en/resources/podcasts/quidelortho-science-bytes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quidelortho Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602190917PR_NEWS_USPR_____LA91086) on February 19, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10